Lexeo Therapeutics, Inc. · NASDAQ:LXEO

Townsend Richard Nolan sold 3,345 Lexeo Therapeutics, Inc. shares (Form 4)

Traded Aug 18, 2026 · Filed Aug 19, 2026

On Aug 18, 2026, Townsend Richard Nolan (Director, Chief Executive Officer) sold 3,345 Lexeo Therapeutics, Inc. shares at US$4.95 for US$16,558, leaving 374,472 shares. Filed Aug 19, 2026 (Form 4).

Sold
3,345 shares
Price
US$4.95
Value
US$16,558
Holding after
374,472 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 18, 2026Common StockSale3,345US$4.95374,472Direct

Source

View original at SEC

Related